| |
| | Purification of Fully Activated Clostridium botulinum Serotype B Toxin for Treatment of Patients with Dystonia -- ... (Site not responding. Last check: 2007-10-19) |
 | | Inoue, K., Y. Fujinaga, K. Honke, H. Arimitsu, N. Mahmut, Y. Sakaguchi, T. Ohyama, T. Watanabe, K. Inoue, and K. Oguma. |
 | | The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials. |
 | | Fujinaga, Y., Inoue, K., Watarai, S., Sakaguchi, Y., Arimitsu, H., Lee, J.-C., Jin, Y., Matsumura, T., Kabumoto, Y., Watanabe, T., Ohyama, T., Nishikawa, A., Oguma, K. Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes. |
| iai.asm.org /cgi/content/full/71/3/1599 (2608 words) |
|